Literature DB >> 27403880

A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloids-β accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload.

Jirapas Sripetchwandee1, Suwakon Wongjaikam1, Warunsorn Krintratun1, Nipon Chattipakorn1, Siriporn C Chattipakorn2.   

Abstract

Iron-overload can cause cognitive impairment due to blood-brain barrier (BBB) breakdown and brain mitochondrial dysfunction. Although deferiprone (DFP) has been shown to exert neuroprotection, the head-to-head comparison among iron chelators used clinically on brain iron-overload has not been investigated. Moreover, since antioxidant has been shown to be beneficial in iron-overload condition, its combined effect with iron chelator has not been tested. Therefore, the hypothesis is that all chelators provide neuroprotection under iron-overload condition, and that a combination of an iron chelator with an antioxidant has greater efficacy than monotherapy. Male Wistar rats (n=42) were assigned to receive a normal diet (ND) or a high-iron diet (HFe) for 4months. At the 2nd month, HFe-fed rats were treated with a vehicle, deferoxamine (DFO), DFP, deferasirox (DFX), n-acetyl cysteine (NAC) or a combination of DFP with NAC, while ND-fed rats received vehicle. At the end of the experiment, rats were decapitated and brains were removed to determine brain iron level and deposition, brain mitochondrial function, BBB protein expression, brain mitochondrial dynamic, brain apoptosis, tau-hyperphosphorylation, amyloid-β (Aβ) accumulation and dendritic spine density. The results showed that iron-overload induced BBB breakdown, brain iron accumulation, brain mitochondrial dysfunction, impaired brain mitochondrial dynamics, tau-hyperphosphorylation, Aβ accumulation and dendritic spine reduction. All treatments, except DFX, attenuated these impairments. Moreover, combined therapy provided a greater efficacy than monotherapy. These findings suggested that iron-overload induced brain iron toxicity and a combination of an iron chelator with an antioxidant provided a greatest efficacy for neuroprotection than monotherapy.
Copyright © 2016 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  combined therapy; dendritic spine; iron chelator; iron-overload; mitochondrial dynamic

Mesh:

Substances:

Year:  2016        PMID: 27403880     DOI: 10.1016/j.neuroscience.2016.07.003

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  20 in total

1.  Iron dysregulates APP processing accompanying with sAPPα cellular retention and β-secretase inhibition in rat cortical neurons.

Authors:  Yu-Ting Chen; Wu-Yan Chen; Xiao-Tian Huang; Ye-Chun Xu; Hai-Yan Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-08-24       Impact factor: 6.150

Review 2.  Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update.

Authors:  Richard Gordan; Suwakon Wongjaikam; Judith K Gwathmey; Nipon Chattipakorn; Siriporn C Chattipakorn; Lai-Hua Xie
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

3.  Increasing Intracellular Levels of Iron with Ferric Ammonium Citrate Leads to Reduced P-glycoprotein Expression in Human Immortalised Brain Microvascular Endothelial Cells.

Authors:  Stephanie A Newman; Yijun Pan; Jennifer L Short; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2021-02-02       Impact factor: 4.200

Review 4.  Iron overload cardiomyopathy: Using the latest evidence to inform future applications.

Authors:  Sirinart Kumfu; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Exp Biol Med (Maywood)       Date:  2022-02-07

Review 5.  The Emerging Roles of Ferroptosis in Huntington's Disease.

Authors:  Yajing Mi; Xingchun Gao; Hao Xu; Yuanyuan Cui; Yuelin Zhang; Xingchun Gou
Journal:  Neuromolecular Med       Date:  2019-01-02       Impact factor: 3.843

Review 6.  Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation.

Authors:  Zahra Yarjanli; Kamran Ghaedi; Abolghasem Esmaeili; Soheila Rahgozar; Ali Zarrabi
Journal:  BMC Neurosci       Date:  2017-06-26       Impact factor: 3.288

7.  Restoring the impaired cardiac calcium homeostasis and cardiac function in iron overload rats by the combined deferiprone and N-acetyl cysteine.

Authors:  Suwakon Wongjaikam; Sirinart Kumfu; Juthamas Khamseekaew; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

8.  Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy.

Authors:  Subhash K Das; Pavel Zhabyeyev; Ratnadeep Basu; Vaibhav B Patel; Jason R B Dyck; Zamaneh Kassiri; Gavin Y Oudit
Journal:  Biosci Rep       Date:  2018-01-10       Impact factor: 3.840

9.  Iron Exposure and the Cellular Mechanisms Linked to Neuron Degeneration in Adult Mice.

Authors:  Lin-Bo Li; Rui Chai; Shuai Zhang; Shuang-Feng Xu; Yan-Hui Zhang; Hai-Long Li; Yong-Gang Fan; Chuang Guo
Journal:  Cells       Date:  2019-02-24       Impact factor: 6.600

Review 10.  Iron and Alzheimer's Disease: From Pathogenesis to Therapeutic Implications.

Authors:  Jun-Lin Liu; Yong-Gang Fan; Zheng-Sheng Yang; Zhan-You Wang; Chuang Guo
Journal:  Front Neurosci       Date:  2018-09-10       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.